Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Leukemia, Myeloid, Acute 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Myelodysplastic Syndromes 27Multiple Myeloma 20Recurrence 19Lymphoma, Non-Hodgkin 15Lymphoma, B-Cell 14Lymphoma 14Leukemia, Lymphocytic, Chronic, B-Cell 13Ovarian Neoplasms 12Hematologic Neoplasms 12Melanoma 11Pancreatic Neoplasms 10Myeloproliferative Disorders 10Burkitt Lymphoma 10Leukemia 9Hodgkin Disease 9Stomach Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Biphenotypic, Acute 8Neoplasms 7Leukemia, Myelomonocytic, Chronic 7Colorectal Neoplasms 7Triple Negative Breast Neoplasms 6Osteosarcoma 6Neuroblastoma 6Neoplasm Metastasis 6Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6

Interventions

Cisplatin 18Gemcitabine 14Radiotherapy, Intensity-Modulated 11Magnetic Resonance Spectroscopy 8toripalimab 7Specimen Handling 7Capecitabine 7Platinum 5Drug Therapy 51,2-diaminocyclohexaneplatinum II citrate 5camrelizumab 4Radiotherapy 4Nivolumab 4spartalizumab 3sintilimab 3anlotinib 3Immunoglobulin G 3Immune Checkpoint Inhibitors 3Docetaxel 3Disulfides 3atezolizumab 2Radiation 2Phantoms, Imaging 2Ipilimumab 2Carboplatin 2CTLA-4 Antigen 2Biopsy 2Bevacizumab 218-O-demethylcervinomycin A2 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Carcinoma × fludarabine × 90 days × Clear all
NCT02287311 2026-03-23

MABEL

Baylor College of Medicine

Phase 1 Active not recruiting
38 enrolled 16 charts
Head & NeckLymphoid

Nasopharyngeal Carcinoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Smooth Muscle Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡